Sibutramine: balancing weight loss benefit and possible cardiovascular risk.
de Simone
Giovanni
G
D'Addeo
Gianpaolo
G
D000928:Antidepressive Agents / Q000009:adverse effects*; D001067:Appetite Depressants / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000517:prevention & control; D003503:Cyclobutanes / Q000009:adverse effects*; D004435:Eating / Q000187:drug effects*; D019317:Evidence-Based Medicine; D006801:Humans; D009765:Obesity / Q000188:drug therapy* / Q000503:physiopathology; D018579:Patient Selection; D018570:Risk Assessment; D012720:Severity of Illness Index; D015431:Weight Loss / Q000187:drug effects*
D000928:Antidepressive Agents; D001067:Appetite Depressants; D003503:Cyclobutanes; C058254:sibutramine